[Heart function in @entity1 with XXXX ].

@entity1 @entity101 @entity6 @entity2294 @entity2 @entity299 @entity453 @entity3483
BACKGROUND: To evaluate the incidence and effective factors of @entity299 in @entity1 with @entity2 . METHODS: Echocardiography were carried out in 60 @entity1 with @entity2 before treatment. According to heart function, @entity1 were divided into treatment group and control group. RESULTS: The incidence of @entity299 in @entity1 with @entity2 was 60%. All @entity1 with @entity3483 and @entity2294 had @entity299 . @entity299 occurred much earlier when @entity1 had previous history of @entity453 , @entity101 or @entity6 . Treatment against @entity299 may improve symptoms and prolong survival time. The @entity299 in the @entity1 with @entity2 is not concerned in chemotherapy. CONCLUSIONS: The incidence of @entity299 is closely related to @entity1 ' general condition, especially massive @entity3483 and @entity2294 . Treatment against @entity299 can significantly improve the clinical symptoms, life quality and survival time.
